Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AXAFA: Apixaban vs VKA for AF Ablation
NCT02227550Phase 4Completed
- Sponsor
- Kompetenznetz Vorhofflimmern
- Start
- Dec 2014
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 4 trial of apixaban in Atrial fibrillation (AFib), sponsored by Kompetenznetz Vorhofflimmern. Started Dec 2014; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02227550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02227550.